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Abstract
Inflammatory myofibroblastic tumours are reported to occur in a variety of sites, including the head
and neck, abdominal organs, central nervous system and urinary tract. They only rarely occur in
the lung.
We report a case of a 25-year-old male admitted with haemoptysis. His chest radiograph showed
a peripheral right lung opacity and computed tomography revealed a right lower lobe soft tissue
density mass. Bronchoscopy and fine needle aspiration were unhelpful. a diagnosis of pulmonary
carcinoma was made, and the patient underwent a right lower lobectomy. On pathology, the tumor
was found to be an inflammatory pseudotumor. These lesion are extremely rare, constituting less
than 1% of pulmonary malignancies, but are known to occur in young patients. We believe clinicians
need to retain an index of suspicion for the presence of this disease in young patients, which can
masquerade as more common malignancies.
Introduction
Inflammatory myofibroblastic tumor (IMT) is a rare dis-
ease that usually occurs in the lung. It is also known as
plasma cell granuloma, inflammatory pseudotumor, xan-
thogranuloma and fibrous histiocytoma [1]. The notion
of IMT being a reactive lesion or a neoplasm is controver-
sial [2]. Because of its rarity, its biologic nature, natural
history and response to treatment have yet to be com-
pletely defined. A case of a 25-year-old male who was
admitted with hemoptysis, right lung mass and under-
went a right lower lobectomy is presented. Biopsy of the
resected specimen confirmed the diagnosis of an IMT.
Case presentation
A 25 year-old-male presented with a history of cough with
bloody mucoid sputum for the previous two months. He
also had anorexia and a history of intermittent upper res-
piratory tract infections for two years. Clinical examina-
tion revealed diminished breath sounds at the right lung
base. Laboratory investigation reported normochromic –
normocytic anaemia, with low iron serum level and ele-
vated erythrocyte sedimentation rate (76 mm/first hour).
His chest radiograph revealed a perbipheral right lung
opacity, and computed tomography (CT) demonstrated a
right lower lobe soft tissue density mass [Figures 1, 2].
Enlarged mediastinal lymph nodes were not identified.
Bronchoscopy was negative. Transthoracic fine-needle
aspiration under CT guidance was not diagnostic. A com-
plete study of bone, brain and abdomen was also per-
formed to assess the stage of a presumed bronchogenic
carcinoma and no extrapulmonary involvement was
noted. Surgery was carried out to obtain diagnosis and
achieve cure. The patient underwent a right lower lobec-
tomy and complete lymph node dissection through a
right posterolateral thoracotomy. Macroscopically, the
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mass appeared well-circumscribed and yellowish in col-
our on cut section. Microscopically the mass was com-
posed of fibroblasts, collagen and inflammatory cells
mainly of lymphocytes and plasma cells (Figure 3). There
was no mitotic activity. No microorganisms were detected
even on special stains. The overall features suggested an
inflammatory pseudotumor. All lymph nodes were nega-
tive for malignancy. The postoperative period was une-
ventful and the patient discharged home on postoperative
day 10. The patient remained well and asymptomatic two
years later.
Discussion
Inflammatory myofibroblastic tumor of the lung is rare
and its incidence is reported to be 0.04–1% of all pulmo-
nary tumours [1]. Although these lesions can grow at a
wide variety of other sites, they usually arise within the
lung [3]. Pulmonary IMT is the most common lung tumor
in patients younger than 16 years, and there does not
appear to be a predilection for sex [4,5].
Common symptoms include cough, dyspnoea, fever,
pleuritic pain and haemoptysis. A significant proportion
of cases (30–70%) remain asymptomatic [4]. A history of
upper respiratory tract infections or pneumonia is
reported in approximately 30% of cases [6]. In our case,
anorexia and hemoptysis were the main symptoms and a
history of previous respiratory infection was also reported.
Occasional cases of inflammatory pseudotumors of the
lung are reported in which bacteria and fungi are isolated
[7].
Previous studies have reported anaemia, elevated erythro-
cyte sedimentation rate, thrombocytosis and polyclonal
hypergammaglobulinemia [8,9]. The first two findings
were detected in our patient.
The radiologic features of inflammatory pseudotumors of
the lung have been analyzed by Agrons et al [10]. Com-
puted tomographic scan shows a nodule or a mass in
approximately 90% of patients and multiple nodules in
5%. Secondary infiltration of hilum, mediastinum and
airways occurs rarely. Calcification or cavitation is also
reported but it is very infrequent [11]. Generally, com-
puted tomography is not able to identify any specific fea-
tures of inflammatory pseudotumors and all patients are
eligible for surgery with suspected lung cancer as the diag-
nosis.
Needle biopsy has been suggested as a feasible approach
to the diagnosis [12]. Fine needle aspiration shows a mix-
ture of inflammatory cells, including plasma cells, fibrob-
lasts and pneumocytes. Such findings are non-specific,
given that inflammatory lesions of different origin can
present the same picture. Moreover, inflammation and
fibrosis can sometimes represent a reaction around a
malignant tumor. Cerfolio et al proposed that these pre-
operative procedures are unnecessary and recommended
complete resection for both diagnosis and treatment [1].
Attempted fine-needle aspiration cytology in our case also
failed to establish diagnosis.
Gross pathology demonstrates that pulmonary inflamma-
tory pseudotumors typically form a well-defined, firm,
lobulated parenchymal nodule or mass with a whorled
and often heterogeneous appearance on cut section. His-
tologically, IMT is composed of a variable inflammatory
and mesenchymal cellular mixture including plasma cells,
Computed tomography revealed a right lower lobe soft tis- sue density mass Figure 2
Computed tomography revealed a right lower lobe soft tis-
sue density mass.
Chest x-ray revealed an abnormal shadow on the right lung Figure 1
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histiocytes, lymphocytes and spindle cells. Therefore,
depending on the predominant cellular components,
many synonyms for this disease have been described. Pet-
tinato et al referred to this entity as IMT because the bulk
of the lesion invariably consisted of not specific inflam-
matory cells but proliferative myofibroblasts and fibrob-
lasts [13]. Most of the spindle cells are myofibroblasts,
which show immunohistochemical staining for vimentin
and smooth muscle actin and consistent ultrastructural
features. The spindle cells commonly have low cellular
atypia and no mitotic activity. The differential diagnosis
of IMT is multifarious because of its variable cellular
admixture. It includes malignant lymphoma, lymphoid
hyperplasia, pseudolymphoma, plasmacytoma, malig-
nant fibrous histiocytoma, sarcomatoid carcinoma, scle-
rosing haemangioma, sarcoma and chronic nodular
pneumonitis [14]. These lesions can be differentiated by
careful attention to cellular atypia, necrosis, mitotic activ-
ity, immunoreactivity or clonality [1,2].
The treatment of choice of inflammatory pseudotumor of
the lung is surgery [15]. Wedge resection, if radical is suit-
able for curative purposes. When it is not technically fea-
sible, the lesion is removed with major resection
(lobectomy or pneumonectomy). In some cases, neigh-
bouring anatomic structures (chest wall, diaphragm)also
need to be excised. The effectiveness of radiotherapy,
chemotherapy or steroids is uncertain [1,16]. Spontane-
ous regression of IMT has been reported only infre-
quently. In our case, a right lower lobectomy was
performed with radical lymph node dissection and two
years later the patient is in an excellent condition under-
going a stringent and prolonged follow up.
The prognosis of patients who undergo radical resection is
excellent [1,7]. Nevertheless, relapse can occur even many
years after resection and disease-related deaths are
reported [17]. In recent years, inflammatory pseudotumor
of the lung with considerable biologic aggressiveness and
unfavourable evolution have been described with increas-
ing frequency. Death is secondary to both local relapse
with infiltration of the mediastinal organs and distant
metastases [18].
In conclusion, IMT is a rare disease with similar character-
istics to those of a true tumor. clinicians should retain an
index of suspicion for the presence of this disease in
young patients with symptoms or chest radiographs
which suggest the presence of a malignancy. Surgical
resection when possible, is recommended as the treat-
ment of choice with an excellent outcome. Long-term fol-
low up is imperative to detect recurrence.
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The mass was composed of fibroblasts, collagen and inflam- matory cells mainly of lymphocytes and plasma cells (Hema- toxylin-Eosin × 100) Figure 3
The mass was composed of fibroblasts, collagen and inflam-
matory cells mainly of lymphocytes and plasma cells (Hema-
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